Selected research
Industry Research
Fibrin Degradation Products (FDP) Assay Kit Industry Research Report 2026
Market perspective
The global Fibrin Degradation Products (FDP) Assay Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fibrin Degradation Products (FDP) Assay Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fibrin Degradation Products (FDP) Assay Kit is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fibrin Degradation Products (FDP) Assay Kit is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fibrin Degradation Products (FDP) Assay Kit include Biolinks, CUSABIO, Elabscience Biotechnology, ELK Biotechnology, Kamiya Biomedical Company, Novatein Biosciences, Novus Biologicals, Weldon and Chuanzhi Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fibrin Degradation Products (FDP) Assay Kit market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fibrin Degradation Products (FDP) Assay Kit Market by Company
Biolinks
CUSABIO
Elabscience Biotechnology
ELK Biotechnology
Kamiya Biomedical Company
Novatein Biosciences
Novus Biologicals
Weldon
Chuanzhi Biotechnology
Gaining Biology
Thermo Fisher Scientific
Syscan
Yifeixue Biotechnology
Fibrin Degradation Products (FDP) Assay Kit Segment by Type
Human FDP Assay Kit
Rat FDP Assay Kit
Others
Fibrin Degradation Products (FDP) Assay Kit Segment by Application
Clinical Diagnosis
Scientific Research
Other
Fibrin Degradation Products (FDP) Assay Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrin Degradation Products (FDP) Assay Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrin Degradation Products (FDP) Assay Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrin Degradation Products (FDP) Assay Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fibrin Degradation Products (FDP) Assay Kit manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fibrin Degradation Products (FDP) Assay Kit by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fibrin Degradation Products (FDP) Assay Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human FDP Assay Kit
- Rat FDP Assay Kit
- Others
Applications
- Clinical Diagnosis
- Scientific Research
- Other
Companies covered
- Biolinks
- CUSABIO
- Elabscience Biotechnology
- ELK Biotechnology
- Kamiya Biomedical Company
- Novatein Biosciences
- Novus Biologicals
- Weldon
- Chuanzhi Biotechnology
- Gaining Biology
- Thermo Fisher Scientific
- Syscan
- Yifeixue Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fibrin Degradation Products (FDP) Assay Kit Market Size (2021-2032)
- 2.2.2 Global Fibrin Degradation Products (FDP) Assay Kit Sales (2021-2032)
- 2.2.3 Global Fibrin Degradation Products (FDP) Assay Kit Market Average Price (2021-2032)
- 2.3 Fibrin Degradation Products (FDP) Assay Kit by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Human FDP Assay Kit
- 2.3.3 Rat FDP Assay Kit
- 2.3.4 Others
- 2.4 Fibrin Degradation Products (FDP) Assay Kit by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinical Diagnosis
- 2.4.3 Scientific Research
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fibrin Degradation Products (FDP) Assay Kit Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fibrin Degradation Products (FDP) Assay Kit Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Fibrin Degradation Products (FDP) Assay Kit Revenue of Manufacturers (2021-2026)
- 3.4 Global Fibrin Degradation Products (FDP) Assay Kit Average Price by Manufacturers (2021-2026)
- 3.5 Global Fibrin Degradation Products (FDP) Assay Kit Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fibrin Degradation Products (FDP) Assay Kit, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fibrin Degradation Products (FDP) Assay Kit, Product Type & Application
- 3.8 Global Manufacturers of Fibrin Degradation Products (FDP) Assay Kit, Established Date
- 3.9 Global Fibrin Degradation Products (FDP) Assay Kit Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Biolinks
- 4.1.1 Biolinks Company Information
- 4.1.2 Biolinks Business Overview
- 4.1.3 Biolinks Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Biolinks Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.1.5 Biolinks Recent Developments
- 4.2 CUSABIO
- 4.2.1 CUSABIO Company Information
- 4.2.2 CUSABIO Business Overview
- 4.2.3 CUSABIO Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CUSABIO Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.2.5 CUSABIO Recent Developments
- 4.3 Elabscience Biotechnology
- 4.3.1 Elabscience Biotechnology Company Information
- 4.3.2 Elabscience Biotechnology Business Overview
- 4.3.3 Elabscience Biotechnology Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Elabscience Biotechnology Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.3.5 Elabscience Biotechnology Recent Developments
- 4.4 ELK Biotechnology
- 4.4.1 ELK Biotechnology Company Information
- 4.4.2 ELK Biotechnology Business Overview
- 4.4.3 ELK Biotechnology Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ELK Biotechnology Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.4.5 ELK Biotechnology Recent Developments
- 4.5 Kamiya Biomedical Company
- 4.5.1 Kamiya Biomedical Company Company Information
- 4.5.2 Kamiya Biomedical Company Business Overview
- 4.5.3 Kamiya Biomedical Company Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kamiya Biomedical Company Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.5.5 Kamiya Biomedical Company Recent Developments
- 4.6 Novatein Biosciences
- 4.6.1 Novatein Biosciences Company Information
- 4.6.2 Novatein Biosciences Business Overview
- 4.6.3 Novatein Biosciences Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novatein Biosciences Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.6.5 Novatein Biosciences Recent Developments
- 4.7 Novus Biologicals
- 4.7.1 Novus Biologicals Company Information
- 4.7.2 Novus Biologicals Business Overview
- 4.7.3 Novus Biologicals Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novus Biologicals Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.7.5 Novus Biologicals Recent Developments
- 4.8 Weldon
- 4.8.1 Weldon Company Information
- 4.8.2 Weldon Business Overview
- 4.8.3 Weldon Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Weldon Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.8.5 Weldon Recent Developments
- 4.9 Chuanzhi Biotechnology
- 4.9.1 Chuanzhi Biotechnology Company Information
- 4.9.2 Chuanzhi Biotechnology Business Overview
- 4.9.3 Chuanzhi Biotechnology Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Chuanzhi Biotechnology Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.9.5 Chuanzhi Biotechnology Recent Developments
- 4.10 Gaining Biology
- 4.10.1 Gaining Biology Company Information
- 4.10.2 Gaining Biology Business Overview
- 4.10.3 Gaining Biology Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gaining Biology Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.10.5 Gaining Biology Recent Developments
- 4.11 Thermo Fisher Scientific
- 4.11.1 Thermo Fisher Scientific Company Information
- 4.11.2 Thermo Fisher Scientific Business Overview
- 4.11.3 Thermo Fisher Scientific Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Thermo Fisher Scientific Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.11.5 Thermo Fisher Scientific Recent Developments
- 4.12 Syscan
- 4.12.1 Syscan Company Information
- 4.12.2 Syscan Business Overview
- 4.12.3 Syscan Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Syscan Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.12.5 Syscan Recent Developments
- 4.13 Yifeixue Biotechnology
- 4.13.1 Yifeixue Biotechnology Company Information
- 4.13.2 Yifeixue Biotechnology Business Overview
- 4.13.3 Yifeixue Biotechnology Fibrin Degradation Products (FDP) Assay Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Yifeixue Biotechnology Fibrin Degradation Products (FDP) Assay Kit Product Portfolio
- 4.13.5 Yifeixue Biotechnology Recent Developments
5 Global Fibrin Degradation Products (FDP) Assay Kit Market Scenario by Region
- 5.1 Global Fibrin Degradation Products (FDP) Assay Kit Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Region: 2021-2032
- 5.2.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Region: 2021-2026
- 5.2.2 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Region: 2027-2032
- 5.3 Global Fibrin Degradation Products (FDP) Assay Kit Revenue by Region: 2021-2032
- 5.3.1 Global Fibrin Degradation Products (FDP) Assay Kit Revenue by Region: 2021-2026
- 5.3.2 Global Fibrin Degradation Products (FDP) Assay Kit Revenue by Region: 2027-2032
- 5.4 North America Fibrin Degradation Products (FDP) Assay Kit Market Facts & Figures by Country
- 5.4.1 North America Fibrin Degradation Products (FDP) Assay Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fibrin Degradation Products (FDP) Assay Kit Sales by Country (2021-2032)
- 5.4.3 North America Fibrin Degradation Products (FDP) Assay Kit Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fibrin Degradation Products (FDP) Assay Kit Market Facts & Figures by Country
- 5.5.1 Europe Fibrin Degradation Products (FDP) Assay Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fibrin Degradation Products (FDP) Assay Kit Sales by Country (2021-2032)
- 5.5.3 Europe Fibrin Degradation Products (FDP) Assay Kit Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fibrin Degradation Products (FDP) Assay Kit Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fibrin Degradation Products (FDP) Assay Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fibrin Degradation Products (FDP) Assay Kit Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fibrin Degradation Products (FDP) Assay Kit Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fibrin Degradation Products (FDP) Assay Kit Market Facts & Figures by Country
- 5.7.1 South America Fibrin Degradation Products (FDP) Assay Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fibrin Degradation Products (FDP) Assay Kit Sales by Country (2021-2032)
- 5.7.3 South America Fibrin Degradation Products (FDP) Assay Kit Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fibrin Degradation Products (FDP) Assay Kit Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fibrin Degradation Products (FDP) Assay Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fibrin Degradation Products (FDP) Assay Kit Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fibrin Degradation Products (FDP) Assay Kit Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Type (2021-2032)
- 6.1.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Fibrin Degradation Products (FDP) Assay Kit Sales Market Share by Type (2021-2032)
- 6.2 Global Fibrin Degradation Products (FDP) Assay Kit Revenue by Type (2021-2032)
- 6.2.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fibrin Degradation Products (FDP) Assay Kit Revenue Market Share by Type (2021-2032)
- 6.3 Global Fibrin Degradation Products (FDP) Assay Kit Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Application (2021-2032)
- 7.1.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Fibrin Degradation Products (FDP) Assay Kit Sales Market Share by Application (2021-2032)
- 7.2 Global Fibrin Degradation Products (FDP) Assay Kit Revenue by Application (2021-2032)
- 7.2.1 Global Fibrin Degradation Products (FDP) Assay Kit Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fibrin Degradation Products (FDP) Assay Kit Revenue Market Share by Application (2021-2032)
- 7.3 Global Fibrin Degradation Products (FDP) Assay Kit Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fibrin Degradation Products (FDP) Assay Kit Value Chain Analysis
- 8.1.1 Fibrin Degradation Products (FDP) Assay Kit Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fibrin Degradation Products (FDP) Assay Kit Production Mode & Process
- 8.2 Fibrin Degradation Products (FDP) Assay Kit Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fibrin Degradation Products (FDP) Assay Kit Distributors
- 8.2.3 Fibrin Degradation Products (FDP) Assay Kit Customers
9 Global Fibrin Degradation Products (FDP) Assay Kit Analyzing Market Dynamics
- 9.1 Fibrin Degradation Products (FDP) Assay Kit Industry Trends
- 9.2 Fibrin Degradation Products (FDP) Assay Kit Industry Drivers
- 9.3 Fibrin Degradation Products (FDP) Assay Kit Industry Opportunities and Challenges
- 9.4 Fibrin Degradation Products (FDP) Assay Kit Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst